propofol has been researched along with 2019 Novel Coronavirus Disease in 30 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A higher-than-usual resistance to standard sedation regimens in COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) has led to the frequent use of the second-line anaesthetic agent ketamine." | 8.12 | Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome. ( Andermatt, R; Bartussek, J; Buehler, PK; Camen, G; David, S; Erlebach, R; Hofmaenner, DA; Jüngst, C; Müllhaupt, B; Schuepbach, RA; Wendel-Garcia, PD, 2022) |
| "Propofol was promptly discontinued." | 5.91 | Refractory atrial fibrillation with rapid ventricular response as a heralding sign of propofol infusion syndrome in a patient with COVID-19. ( Henley, E; Siddiqui, MN; Xue, B, 2023) |
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 5.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| "A higher-than-usual resistance to standard sedation regimens in COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) has led to the frequent use of the second-line anaesthetic agent ketamine." | 4.12 | Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome. ( Andermatt, R; Bartussek, J; Buehler, PK; Camen, G; David, S; Erlebach, R; Hofmaenner, DA; Jüngst, C; Müllhaupt, B; Schuepbach, RA; Wendel-Garcia, PD, 2022) |
| "Hypertriglyceridemia occurred frequently in patients with COVID-19 who received propofol but did not lead to acute pancreatitis." | 4.12 | The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019. ( Abedian, S; An, A; Barie, PS; Berger, K; Littlefield, AJ; Witenko, CJ, 2022) |
| "Propofol was infused at 1." | 1.91 | Unusual case of propofol-related infusion syndrome complicating severe COVID-19 ARDS. ( Babu, VK; Garcia-Fernandez, A; Perez Del Nogal, G; Rojas, P, 2023) |
| "Propofol was promptly discontinued." | 1.91 | Refractory atrial fibrillation with rapid ventricular response as a heralding sign of propofol infusion syndrome in a patient with COVID-19. ( Henley, E; Siddiqui, MN; Xue, B, 2023) |
| "Propofol was exclusively administered by anesthetists according to 94% of answers, and for 6% of respondents the endoscopist is allowed to administer propofol in presence of a dedicated nurse, but with a readily available anesthetist." | 1.91 | Rethink analgo-sedation in digestive endoscopy: the role of scientific societies in tracing training path. ( Conigliaro, R; De Robertis, E; Fanti, L; Martino, R; Monzani, R; Pasquale, L; Petrini, F; Pietrini, L; Rossi, M; Sbaraglia, F; Tritapepe, L, 2023) |
| "Phenobarbital was trialed for possible propofol withdrawal syndrome, allowing for a dose reduction of 10 μg/kg/min within 2 hours of the first dose without any corresponding symptoms." | 1.91 | Successful management of suspected propofol dependence with phenobarbital in an adult patient with COVID-19. ( Feeney, ME; Steiling, K, 2023) |
| "Status Epilepticus is the most common non-traumatic neurologic emergency in childhood." | 1.72 | Resolution of status epilepticus after ketamine administration. ( Hakmeh, W; Howing, CE; Razi, F, 2022) |
| "Pneumonia caused by coronavirus disease 2019 (COVID-19) is a highly contagious disease." | 1.62 | A Case Report of Sedation Strategy for a Patient With Coronavirus Disease 2019 Supported by Extracorporeal Membrane Oxygenation After Cesarean Section. ( Cheng, Z; Li, B; Liao, X; Wen, J, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 30 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| El Nekidy, WS | 1 |
| Shatnawei, A | 1 |
| Abdelsalam, MM | 1 |
| Hassan, M | 1 |
| Dajani, RZ | 1 |
| Salem, N | 1 |
| St John, TJL | 1 |
| Rahman, N | 1 |
| Hamed, F | 1 |
| Mallat, J | 1 |
| Witenko, CJ | 2 |
| Littlefield, AJ | 2 |
| Abedian, S | 2 |
| An, A | 2 |
| Barie, PS | 2 |
| Berger, K | 2 |
| Sohn, JT | 2 |
| Howing, CE | 1 |
| Razi, F | 1 |
| Hakmeh, W | 1 |
| Viana, MV | 1 |
| Pantet, O | 1 |
| Charrière, M | 1 |
| Favre, D | 1 |
| Piquilloud, L | 1 |
| Schneider, AG | 1 |
| Hurni, CA | 1 |
| Berger, MM | 1 |
| Wendel-Garcia, PD | 1 |
| Erlebach, R | 1 |
| Hofmaenner, DA | 1 |
| Camen, G | 1 |
| Schuepbach, RA | 1 |
| Jüngst, C | 1 |
| Müllhaupt, B | 1 |
| Bartussek, J | 1 |
| Buehler, PK | 1 |
| Andermatt, R | 1 |
| David, S | 1 |
| Koutsogiannaki, S | 1 |
| Bu, W | 1 |
| Maisat, W | 1 |
| Manzor, M | 1 |
| Zhang, Z | 1 |
| Ohto, U | 1 |
| Eckenhoff, RG | 1 |
| Yuki, K | 1 |
| Wiemann, B | 3 |
| Mitchell, J | 3 |
| Sarangarm, P | 3 |
| Miskimins, R | 3 |
| Babu, VK | 1 |
| Rojas, P | 1 |
| Perez Del Nogal, G | 1 |
| Garcia-Fernandez, A | 1 |
| Rooimans, T | 1 |
| Damen, M | 1 |
| Markesteijn, CMA | 1 |
| Schuurmans, CCL | 1 |
| de Zoete, NHC | 1 |
| van Hasselt, PM | 1 |
| Hennink, WE | 1 |
| van Nostrum, CF | 1 |
| Hermes, M | 1 |
| Besseling, R | 1 |
| Vromans, H | 1 |
| Siddiqui, MN | 1 |
| Henley, E | 1 |
| Xue, B | 1 |
| Rossi, M | 1 |
| Tritapepe, L | 1 |
| Conigliaro, R | 1 |
| Fanti, L | 1 |
| Monzani, R | 1 |
| De Robertis, E | 1 |
| Martino, R | 1 |
| Pietrini, L | 1 |
| Sbaraglia, F | 1 |
| Pasquale, L | 1 |
| Petrini, F | 1 |
| Feeney, ME | 1 |
| Steiling, K | 1 |
| Payen, JF | 1 |
| Chanques, G | 1 |
| Futier, E | 1 |
| Velly, L | 1 |
| Jaber, S | 1 |
| Constantin, JM | 1 |
| Lönnqvist, PA | 1 |
| Bell, M | 1 |
| Karlsson, T | 1 |
| Wiklund, L | 1 |
| Höglund, AS | 1 |
| Larsson, L | 1 |
| Soh, M | 2 |
| Hifumi, T | 2 |
| Isokawa, S | 2 |
| Shimizu, M | 2 |
| Otani, N | 2 |
| Ishimatsu, S | 2 |
| Jiang, S | 1 |
| Petriceks, AH | 1 |
| Burke, H | 1 |
| Stern, TA | 1 |
| Senthilkumaran, S | 1 |
| Koushik, M | 1 |
| Sanjay, P | 1 |
| Thirumalaikolundusubramanian, P | 1 |
| Charbonneau, H | 1 |
| Mrozek, S | 1 |
| Pradere, B | 1 |
| Cornu, JN | 1 |
| Misrai, V | 1 |
| Lucchetta, V | 1 |
| Bonvicini, D | 1 |
| Ballin, A | 1 |
| Tiberio, I | 1 |
| Hirota, K | 1 |
| Lambert, DG | 1 |
| Yamamoto, K | 1 |
| Liao, X | 1 |
| Cheng, Z | 1 |
| Wen, J | 1 |
| Li, B | 1 |
| Wei, P | 1 |
| Zheng, Q | 1 |
| Ye, H | 1 |
| Lyu, W | 1 |
| Li, J | 1 |
| Yang, JJ | 1 |
| Kermad, A | 1 |
| Speltz, J | 1 |
| Danziger, G | 1 |
| Mertke, T | 1 |
| Bals, R | 1 |
| Volk, T | 1 |
| Lepper, PM | 1 |
| Meiser, A | 1 |
| Waters, TW | 1 |
| Dickens, DS | 1 |
| Gutierrez, J | 1 |
| Sepulveda, W | 1 |
| Ramirez, R | 1 |
| Acosta, G | 1 |
| Ambiado, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19[NCT05336656] | 353 participants (Actual) | Observational | 2022-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for propofol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Sedation for critically ill patients with COVID-19: Which specificities? One size does not fit all.
Topics: Analgesics, Opioid; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Deep Sedati | 2020 |
29 other studies available for propofol and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Hypertriglyceridemia in Critically Ill Patients With SARS-CoV-2 Infection.
Topics: Adult; COVID-19; Critical Illness; Female; Humans; Hypertriglyceridemia; Intensive Care Units; Lipas | 2022 |
Reply: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
Topics: Adult; COVID-19; Humans; Hypnotics and Sedatives; Intensive Care Units; Propofol; Respiration, Artif | 2022 |
Comment: The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
Topics: Adult; COVID-19; Humans; Hypnotics and Sedatives; Intensive Care Units; Propofol; Respiration, Artif | 2022 |
Resolution of status epilepticus after ketamine administration.
Topics: Aftercare; Anticonvulsants; COVID-19; Female; Humans; Infant; Ketamine; Levetiracetam; Lorazepam; Pa | 2022 |
Specific nutrition and metabolic characteristics of critically ill patients with persistent COVID-19.
Topics: Aged; COVID-19; Critical Illness; Energy Intake; Female; Humans; Intensive Care Units; Male; Middle | 2022 |
Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome.
Topics: Bilirubin; COVID-19; Critical Illness; Humans; Hypnotics and Sedatives; Ketamine; Liver; Propofol; R | 2022 |
Propofol directly binds to and inhibits TLR7.
Topics: Animals; COVID-19; Dendritic Cells; Humans; Hypnotics and Sedatives; Imiquimod; Interferon-alpha; In | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Tracheotomy in ventilator-dependent patients with COVID-19: a cross-sectional study of analgesia and sedative requirements.
Topics: Analgesia; Analgesics; COVID-19; Cross-Sectional Studies; Dexmedetomidine; Humans; Hypnotics and Sed | 2022 |
Unusual case of propofol-related infusion syndrome complicating severe COVID-19 ARDS.
Topics: Acidosis; Aged; COVID-19; Humans; Hyperlipidemias; Hypertriglyceridemia; Male; Propofol; Propofol In | 2023 |
Development of a compounded propofol nanoemulsion using multiple non-invasive process analytical technologies.
Topics: COVID-19; Emulsions; Humans; Pandemics; Parenteral Nutrition; Propofol | 2023 |
Refractory atrial fibrillation with rapid ventricular response as a heralding sign of propofol infusion syndrome in a patient with COVID-19.
Topics: Atrial Fibrillation; COVID-19; Female; Humans; Hypnotics and Sedatives; Infusions, Intravenous; Prop | 2023 |
Rethink analgo-sedation in digestive endoscopy: the role of scientific societies in tracing training path.
Topics: Anesthesia; Conscious Sedation; COVID-19; Endoscopy, Gastrointestinal; Humans; Hypnotics and Sedativ | 2023 |
Successful management of suspected propofol dependence with phenobarbital in an adult patient with COVID-19.
Topics: Adult; COVID-19; Dexmedetomidine; Fentanyl; Humans; Hypertension; Hypnotics and Sedatives; Male; Mid | 2023 |
Does prolonged propofol sedation of mechanically ventilated COVID-19 patients contribute to critical illness myopathy?
Topics: Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Critical Illness; Humans; Hypnotics and | 2020 |
The authors' response: Propofol and sedation in patients with coronavirus disease 2019.
Topics: Conscious Sedation; Coronavirus; COVID-19; Humans; Hypnotics and Sedatives; Propofol; SARS-CoV-2 | 2021 |
Weaning From Exogenous Sedation in the Era of COVID-19 Infection: Recommendations for Sedation and Its Discontinuation.
Topics: Adult; Analgesics, Opioid; Benzodiazepines; Betacoronavirus; Coronavirus Infections; COVID-19; Depre | 2020 |
The authors' response: Propofol in COVID 19: From basic science to clinical impact.
Topics: COVID-19; Humans; Hypnotics and Sedatives; Neuroleptic Malignant Syndrome; Propofol; SARS-CoV-2 | 2021 |
Propofol in COVID 19 - From basic science to clinical impact.
Topics: COVID-19; Humans; Hypnotics and Sedatives; Propofol; SARS-CoV-2 | 2021 |
Propofol and sedation in patients with coronavirus disease.
Topics: Conscious Sedation; Coronavirus; COVID-19; Humans; Hypnotics and Sedatives; Neuroleptic Malignant Sy | 2021 |
How to resume elective surgery in light of COVID-19 post-pandemic propofol shortage: The common concern of anaesthesists and surgeons.
Topics: Anesthesia, Conduction; Anesthetics, Intravenous; Anesthetists; Attitude of Health Personnel; Betaco | 2020 |
Propofol infusion syndrome in severe COVID-19.
Topics: Betacoronavirus; Conscious Sedation; Coronavirus Infections; COVID-19; Critical Illness; Humans; Hyp | 2020 |
Propofol and SARS-CoV-2 infection.
Topics: Anesthetics, Intravenous; Coronavirus Infections; COVID-19; Critical Illness; Drug Repositioning; Hu | 2020 |
Risk of propofol use for sedation in COVID-19 patient.
Topics: Animals; Betacoronavirus; Conscious Sedation; Coronavirus Infections; COVID-19; Humans; Hypnotics an | 2020 |
A Case Report of Sedation Strategy for a Patient With Coronavirus Disease 2019 Supported by Extracorporeal Membrane Oxygenation After Cesarean Section.
Topics: Cesarean Section; Combined Modality Therapy; COVID-19; Dexmedetomidine; Extracorporeal Membrane Oxyg | 2021 |
Putative antiviral effects of propofol in COVID-19.
Topics: Anesthetics, Intravenous; Angiotensin-Converting Enzyme 2; Antiviral Agents; COVID-19; COVID-19 Drug | 2021 |
The Safety of Continuous Infusion Propofol in Mechanically Ventilated Adults With Coronavirus Disease 2019.
Topics: Acute Disease; Adult; COVID-19; Humans; Intensive Care Units; Pancreatitis; Propofol; Respiration, A | 2022 |
Comparison of isoflurane and propofol sedation in critically ill COVID-19 patients-a retrospective chart review.
Topics: Conscious Sedation; COVID-19; Critical Illness; Humans; Hypnotics and Sedatives; Intensive Care Unit | 2021 |
Reducing sedated lumbar punctures in pediatric patients with acute lymphoblastic leukemia.
Topics: Adolescent; Adult; Child; COVID-19; Female; Humans; Hypnotics and Sedatives; Male; Pain Management; | 2021 |
Fetal Bladder Rupture as a Complication of Adjunctive Therapy in Severe Maternal SARS-CoV-2 Pneumonia.
Topics: Adult; Analgesics, Opioid; COVID-19; Dexmedetomidine; Female; Fentanyl; Humans; Midazolam; Pregnancy | 2022 |